Regarding the vaccine for the new coronavirus of American pharmaceutical giant Johnson & Johnson, Denmark in Scandinavia announced that it will stop using this vaccine after reports of rare cases of blood clots confirmed after inoculation. Did.
Regarding the Johnson & Johnson vaccine, EU-European Union drug regulators "should be described as a rare side reaction" in April when a blood clot that clogs blood vessels such as the brain was confirmed after vaccination. "The benefits of this vaccine outweigh the risks of side effects," he said.
As a result of independent examination on the 3rd, the Danish health authorities have decided to use this vaccine in light of the fact that the infection situation has been suppressed to some extent in Denmark and that other vaccines are being inoculated. Announced to cancel.
Denmark has already stopped vaccination developed by AstraZeneca and others after reports of confirmed cases of blood clots after vaccination, and health officials have decided to maximize the vaccination plan. He said he would be four weeks late.